Clinical Trial Update: Protecting From Pneumococcus in Early Life (The PROPEL Trial) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update focusing on protection from pneumococcus in early life (PROPEL Trial).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Pneumonia | Phase 3 | Status: UNKNOWN